In conclusion, our study demonstrated mRNA expression of PD‐L1, PD‐1 and CTLA‐4 by both neoplastic and immune cells in canine OMs, supporting their role in immunosuppression and in promoting tumour progression. The gene discussed is CD274; the disease is opsoclonus-myoclonus syndrome.